Researchers at the University of Michigan, MoreBetter (Releaf App), LEVEL and Overcome announced they are recruiting California residents to participate in a 12-week study focusing on the efficacy of different cannabinoid capsules and tablets for managing chronic pain "related to Fibromyalgia, Rheumatoid Arthritis, Osteoarthritis, and overall quality of life."

Researchers aim to address the significant gaps in cannabinoid research related to efficacy for specific types of chronic pain, different product formulations and dosing. According to a press release, “normalizing the product type to tablets and capsules,” this study is the first one “to look at efficacy trends related to dosing combined with unique product formulations.”

This study also seeks to help patients and practitioners better understand how to use cannabinoid medicine as a natural and effective therapy in that there are upwards of 40 million people living with these conditions and even more who are struggling with chronic pain.

Calling California Medical Cannabis Users

Eligible California residents interested in participating in this study can do so from home using their smartphones and answering standardized questionnaires about pain and …

Full story available on